| Company Name: |
cjbscvictory |
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
Benzamide, N-(aminoiminomethyl)-4-[(E)-(3-ethyl-2,4,4-trimethyl-2-cyclohexen-1-ylidene)methyl]- manufacturers
- Magmas-IN-1
-
- $216.00
-
2026-05-11
- CAS:1251957-89-7
- Purity:
- Supply Ability: 10g
|
| | Benzamide, N-(aminoiminomethyl)-4-[(E)-(3-ethyl-2,4,4-trimethyl-2-cyclohexen-1-ylidene)methyl]- Basic information |
| | Benzamide, N-(aminoiminomethyl)-4-[(E)-(3-ethyl-2,4,4-trimethyl-2-cyclohexen-1-ylidene)methyl]- Chemical Properties |
| Melting point | 165-167 °C | | density | 1.10±0.1 g/cm3(Predicted) | | pka | 11.59±0.46(Predicted) |
| | Benzamide, N-(aminoiminomethyl)-4-[(E)-(3-ethyl-2,4,4-trimethyl-2-cyclohexen-1-ylidene)methyl]- Usage And Synthesis |
| Uses | Magmas-IN-1 (compound 9) is a small molecule Magmas inhibitor (SMMI). Magmas is mitochondria associated，granulocyte-macrophage colony stimulating factor signaling molecule，as well as a GM-CSF inducible gene in myeloid cells. Magmas-IN-1 inhibits Magmas and modulates mitochondrial function. Magmas-IN-1 also inhibits proliferation in yeast at 4 μM[1]. | | References | [1] Jubinsky PT, et al. Design, synthesis, and biological activity of novel Magmas inhibitors. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3479-82. DOI:10.1016/j.bmcl.2011.03.050 |
| | Benzamide, N-(aminoiminomethyl)-4-[(E)-(3-ethyl-2,4,4-trimethyl-2-cyclohexen-1-ylidene)methyl]- Preparation Products And Raw materials |
|